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Multicenter study of the diagnostic parameters was
conducted by three groups in Poland to determine if
in situ ¯uorescence detection of human cutaneous
melanoma based on digital imaging of spectrally
resolved auto¯uorescence can be used as a tool for a
preliminary selection of patients at increased risk of
the disease. Fluorescence examinations were per-
formed for 7228 pigmented lesions in 4079 subjects.
Histopathologic examinations showed 56 cases of
melanoma. A sensitivity of ¯uorescence detection of
melanoma was 82.7% in agreement with 82.5%
found in earlier work. Using as a reference only the
results of histopathologic examinations obtained for
568 cases we found a speci®city of 59.9% and a posi-
tive predictive value of 17.5% (melanomas versus all
pigmented lesions) or 24% (melanomas versus com-
mon and dysplastic naevi). The speci®city and positive
predictive value found in this work are signi®cantly
lower than reported earlier but still comparable with
those reported for typical screening programs. In con-
clusion, the ¯uorescence method of in situ detection of
melanoma can be used in screening large populations
of patients for a selection of patients who should be
examined by specialists. Key words: auto¯uorescence/
digital imaging/in situ detection/melanoma/naevi. J Invest
Dermatol 117:1449±1451, 2001
C
linical diagnosis of melanoma is based on morpho-
logic criteria of a qualitative nature. Therefore it is
often dif®cult to differentiate on the basis of clinical
aspects between melanoma and a wide range of other
pigmented skin lesions. Grin et al (1990) estimate that
up to 50% of early melanomas may be misdiagnosed during routine
clinical examination, whereas experts achieve a sensitivity of 80%±
90%. According to Miller and Ackerman (1992) dermatologists do
not detect 32% of melanomas. A retrospective study of 44,258
histopathologically examined skin neoplasms including 529 mela-
nomas (Wolf et al, 1998) showed that the referring physicians
correctly diagnosed 70.1% of melanomas. Analyses of ef®cacy of
screening programs show that only between 35% and 50% of
clinically diagnosed melanomas are con®rmed by histopathologic
examinations (Bologna et al, 1990; Koh et al, 1990; Leffel et al,
1993). Better sensitivity of detection is possible with epilumines-
cence microscopy but the improvement depends to a large extent
on the experience of the examiner (Bilek and Braun-Falco, 1990).
Thus, there is a clear need of a new objective methodology
allowing for a more sensitive screening of large numbers of persons.
One of the new approaches to the problem is the application of
methods of so-called tissue spectroscopy. Bono et al (1996) reported
promising results obtained using a diagnostic algorithm based on
recording images of infrared re¯ectance of the skin and pigmented
lesions. Our group has been working for several years on a
diagnostic algorithm for in situ detection of melanoma using
spectrally resolved imaging of auto¯uorescence of the skin excited
with ultraviolet A (UVA) light of very low intensity. Our
diagnostic algorithm is based on a determination of the ratio of
the maximum intensity of the auto¯uorescence recorded outside
the lesions and the minimum intensity found within them.
Preliminary studies involving more than 700 patients showed that
82.5% of melanomas could be detected in this way (Chwirot et al,
1998a). This paper presents results of further studies of the
technique. Over 7000 pigmented lesions were examined in a trial
conducted during 2.5 y by three groups in Poland.
MATERIALS AND METHODS
Method The ¯uorescence method for in situ detection of melanoma of
the skin was described in detail in our previous publications (Chwirot
et al, 1998a; 1998b). Brie¯y, it consists in digital imaging of the
auto¯uorescence of pigmented lesions and of the skin excited with the
366 nm UVA line of a high-pressure Xe±Hg lamp (Hamamatsu, Japan)
and emitted in the blue 475 nm band. The auto¯uorescence is typically
excited in areas of the skin with a diameter of 3±5 cm. Images are
recorded with equipment designed for low light applications and using
procedures allowing for photometric measurements (SpectraSource). The
images are corrected for thermal noise, bias voltages of the pixels, and
variations in the sensitivity of the pixels of a thermoelectrically cooled
CCD matrix. The contrast, gain, etc. are always the same, as required for
photometric measurements. Areas of maximum emission intensity outside
the lesion of interest and of minimum intensity emitted within the lesion
are localized in the images. If the ratio R of the two intensities is equal
to or higher than 7.0 the lesion is classi®ed as melanoma.
Patients The trial was conducted by research groups from Nicholas
Copernicus University in Torun, the Center of Oncology in Warszawa,
and the Pomeranian Medical University in Szczecin. In Torun, all
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persons who volunteered to undergo ¯uorescence examinations were
accepted. Due to a prevention campaign carried out in Torun for several
years both members of the local community and medical staff have
become more aware of melanoma risk factors. In Warszawa and Szczecin
the majority of the patients had been diagnosed ®rst by a dermatologist
or a physician as being at risk of melanoma or other skin cancer. In
Szczecin special attention was paid to cases of multiple naevi. All the
patients gave their informed consent and the study was approved by the
Committee of Ethics of Scienti®c Research at the School of Medicine,
Bydgoszcz, Poland.
In Torun 3831 subjects were enrolled for the study and ¯uorescence
examinations were carried out for 6151 pigmented lesions. In 495 cases
the results of the ¯uorescence examination could be compared with the
results of histopathologic examination of the lesions removed during
surgical examination. Such complete pairs of data were obtained for 49
melanomas (Clark I, six; Clark II, 17; Clark III, 13; Clark IV, ®ve; Clark
V, one; without Clark classi®cation, seven), 354 pigmented naevi, and
92 cases of skin lesions of different types, hereafter referred to as others
(keratosis seborhoica, 24; verruca seborhoica, 21; dermato®broma, 13;
lentigo simplex, nine; hemangioma, ®ve; other lesions of different kinds,
20). Six lesions (four melanomas, two others) were excluded from the
analyses because they had features disqualifying them from ¯uorescence
examinations (crust formation, bleeding, necrosis, etc.).
In Warszawa the ¯uorescence examinations were performed for 410
lesions and 98 patients. The histopathologic data were obtained for 51
cases: two melanomas, 44 naevi, and ®ve others. In Szczecin 667 lesions
were investigated in 150 patients and the results of the histopathologic
examinations were returned for only 22 cases: ®ve melanomas, 16 naevi,
and one other.
RESULTS
Fluorescence examinations were carried out for 4079 patients and
the images of the auto¯uorescence were obtained for 7228
pigmented skin lesions. Histopathologic veri®cation of the ¯uores-
cence data was obtained for 568 cases. A histogram of the R
parameter values obtained for that group is given in Fig 1. This set
of pairs of results was used for assessment of the method, i.e., for
calculations of its sensitivity CM towards melanomas, speci®city
SNM of classifying the lesions as different from melanoma, and
positive predictive value (PPV) for detecting melanomas. The
sensitivity CM found in this trial was 82.7% and was very similar to
the value of 82.5% obtained in our feasibility study (Chwirot et al,
1998a). The speci®city SNM calculated for all the lesions was 59.9%
and was lower than previously reported (78.6%; Chwirot et al,
1998a). Similarly, the PPV calculated for all the lesions (17.5%) and
for a subgroup composed of melanomas and naevi (24%) were
lower than the respective values of 58.9% and 76.7% found in the
feasibility study (Chwirot et al, 1998a). The most probable reason
for obtaining lower values of SNM and PPV was a larger
contribution of cases that were dif®cult to diagnose clinically.
Due to media coverage of our prevention campaigns more
physicians have become aware of the possibility of having their
patients examined with the ¯uorescence method with a resulting
increase in the number of clinically ``dif®cult'' cases contributing to
the pool of histopathologically veri®ed cases.
Both the sensitivity and the speci®city of the method depend on
the choice of the threshold value of the diagnostic parameter R.
The trade-offs between the sensitivity and speci®city are shown in
Fig 2 in the form of a receiver operated curve (ROC) (Wang et al,
1996).
DISCUSSION
The results obtained in this trial con®rmed that using the digital
imaging of skin auto¯uorescence it is possible to detect human
cutaneous melanomas in situ with good sensitivity. Such an
approach may also be useful for long-term systematic monitoring
of the evolution of pigmented lesions.
It should be noticed that in this trial the experts advising the
patients to undergo surgical operations were aware of both the idea
of the trial and of the results of the ¯uorescence examinations.
Taking into account the potentially dangerous consequences of
misdiagnosing the actual melanomas and the high sensitivity of the
method found at the stage of the feasibility study (Chwirot et al,
1998a) it was decided not to use a blind protocol in the trial.
Therefore, a signi®cant majority of the cases for which both the
¯uorescence and the histopathologic results are available were those
of the lesions that were carefully examined by experienced clinical
experts. In such a situation the average speci®city of 59.5% can be
considered a good indicator of the diagnostic potential of the
method for detecting the melanomas. Also the PPV of 17.5% is of
the same order as the values reported for classical screening
programs carried out in U.S.A. and the Netherlands [PPV 11% and
18% according to data presented by Trampisch et al (1997)]. It
should be noticed, however, that according to other studies of
screening programs from 35% to 50% of clinically diagnosed
melanomas are con®rmed by histopathologic examinations
(Bologna et al, 1990; Koh et al, 1990; Leffel et al, 1993; Wolf
et al, 1996).
The origin of the observed auto¯uorescence is not fully
understood. Several biomolecules have been suggested as endo-
genous ¯uorophores: collagen, elastin, and desmosine (Leffel et al,
1988), NADH (Lohmann and Paul, 1988; Lohmann et al, 1991), or
collagen and keratin (Sterenborg et al, 1994, 1995). Also the
biologic mechanisms causing the variations in the spatial distribu-
tions of the auto¯uorescence intensity are not understood. A
plausible hypothesis may be that the spatial distributions of the
auto¯uorescence observed for the skin surrounding the pigmented
lesions may result from responses of the host cells reacting to the
presence of the lesions and to changes in their characteristics due to
processes of their evolution and maturation.
Figure 1. Histogram for the values of the parameter R measured
for lesions histologically classi®ed as melanoma, naevus, or
pigmented lesion of another kind.
Figure 2. ROC curve showing mutual relations between the
sensitivity and speci®city of the method. The two parameters were
calculated for the threshold values of R changing from 8.0 to 6.0 with
steps of 0.5.
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In conclusion the results of the trial con®rmed that the
¯uorescence method of in situ detection of melanomas can be
used in screening large populations of patients for a selection of
patients who should be examined by specialists. It also allows for
long-term monitoring of the evolution of suspected lesions. It is
simple, objective, and does not require exogenous ¯uorescent
agents, and the dose of UVA radiation acquired by a patient during
the examination is much lower (by at least three orders of
magnitude) than the minimal erythema dose (Chwirot et al, 1998a).
This work was supported by a grant from the State Committee for Scienti®c Research
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